Displaying 10 out of 17 results

  1. The Allergan logo is seen in this photo illustration

    Allergan settles Alzheimer's therapy lawsuit for US$750 million

    Allergan Plc would pay US$750 million to settle a class action lawsuit from a group of direct purchasers of Alzheimer's disease therapy Namenda, ...
  2. A sign marks a Biogen facility in Cambridge

    Biogen, Eisai revive plans for Alzheimer's drug, surprising market

    Biogen Inc revived plans on Tuesday to seek U.S. approval for Alzheimer's treatment aducanumab, surprising investors and saying data from more ...